NCT01034592View on ClinicalTrials.gov

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

PHASE1TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions

AnemiaLeukemiaAcute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)

Interventions

DRUG

Lenalidomide

2.5 mg/wk up to 5 mg 3x/wk

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

Jason Robert Gotlib

OTHER

NCT01034592 - Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia | Biotech Hunter | Biotech Hunter